Repligen Reports First Quarter 2022 Financial Results and Updates Full Year 2022 Financial Guidance

Go back to Repligen Reports First Quarter 2022 Financial Results and Updates Full Year 2022 Financial Guidance

Repligen (RGEN) Tops Q1 EPS by 20c; Lowers FY Outlook

April 27, 2022 7:34 AM EDT

Repligen (NASDAQ: RGEN) reported Q1 EPS of $0.92, $0.20 better than the analyst estimate of $0.72. Revenue for the quarter came in at $206.4 million versus the consensus estimate of $185.48 million.

GUIDANCE:

Repligen sees FY2022 EPS of $3.07-$3.15, versus the consensus of $3.25. Repligen sees... More